Phesgo billing
WebWhat does PHESGO treat? PHESGO ® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medicine approved for use in combination with chemotherapy for:. use prior to surgery (neoadjuvant treatment) in adults with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (tumor is greater than 2 cm in diameter or … WebWith the Genentech Oncology Co-pay Assistance Program, eligible patients with commercial insurance could pay as little as $5 per treatment for PHESGO. Co-pay assistance of up to $25,000 is provided per calendar year. Are over the age of 18, or have a Legally Authorized Person over the age of 18 to manage the program.
Phesgo billing
Did you know?
WebJan 1, 2024 · PHESGO™ (pertuzumab, trastuzumab and hyaluronidase-zzxf) Prior Auth Criteria Proprietary Information. Restricted Access – Do not disseminate or copy without … WebIndications Early Breast Cancer. PHESGO ® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is indicated for use in combination with chemotherapy for. the neoadjuvant treatment of adult patients with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (either greater than 2 cm in diameter or node-positive) as part of a complete …
WebPHESGO Access Solutions offers a range of access and reimbursement resources for your patients and practice after PHESGO is prescribed, including help with benefits … WebMay 3, 2024 · They're available Monday to Friday from 9 am to 5 pm on 0808 800 4040. Best wishes, Jenn. Cancer Chat moderator. Report this post. Reply. Teamtwinmuzzy. 1 posts since. 15 Apr 2024.
WebPHESGO ® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medicine approved for use in combination with chemotherapy for: use prior to surgery (neoadjuvant treatment) in adults with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (tumor is greater than 2 cm in diameter or node-positive). WebA regulated natural gas utility serving the city of Chicago. Gas Emergencies: 866-556-6002, Customer Service: 866-556-6001
WebMost common side effects of PHESGO and tips you can try. The most common side effects of PHESGO when given with chemotherapy as part of an early breast cancer regimen are hair loss, nausea, diarrhea, low levels of red blood cells, and weakness. The most common side effects of PHESGO when given with docetaxel for treatment of breast cancer that has …
WebMay 2, 2024 · VI. Billing Code/Availability Information HCPCS Code: J9316 – Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg; 1 billable unit = 10 mg NDC(s): Phesgo (1,200 mg pertuzumab, 600 mg trastuzumab, and 30,000 units hyaluronidase per 15 mL) single-dose vial: 50242-0245-xx ttdfonline/administrationWebThe NDC Code 50242-245-01 is assigned to “Phesgo ” (also known as: “Pertuzumab, Trastuzumab, And Hyaluronidase-zzxf”), a human prescription drug labeled by “Genentech, Inc.”. The product's dosage form is injection, solution, and is administered via subcutaneous form. Additionally ttd fcraWebMar 1, 2024 · PHESGO. PHESGO may harm the unborn baby. You should use effective contraception during treatment with PHESGO and for 7 months after stopping treatment. If you are a male patient taking PHESGO with a female partner who can become pregnant you should use effective contraception during treatment with PHESGO and for 7 months after … ttdeye phone numberWebJul 5, 2024 · The drug, Phesgo, can be used for all stages of HER2-positive breast cancer. Experts say it can be administered at home by a healthcare professional more quickly than infusion treatments. They... ttdeye try onWebPhesgo ® pertuzumab, trastuzumab, and hyaluronidase-zzxf Full Prescribing Information Safety Data Sheets (2 SDS) Side Effect Reporting You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch . You may also report side effects to Genentech at (888) 835-2555. Support & Resources ttdf headquartersWebThe NDC Packaged Code 50242-245-01 is assigned to a package of 1 vial, single-dose in 1 carton / 15 ml in 1 vial, single-dose of Phesgo, a human prescription drug labeled by Genentech, Inc.. The product's dosage form is injection, solution and is administered via subcutaneous form. The following table has all the important details about this ... ttdeye polar lights grayWebNov 16, 2024 · When administered with PHESGO, the recommended initial dose of docetaxel is 75 mg/m 2 administered as an intravenous infusion. The dose may be escalated to 100 mg/m 2 administered every 3 weeks if the initial dose is well tolerated. Administer PHESGO until disease progression or unmanageable toxicity, whichever occurs first. ttd fish pie